Author Archives: clinicalaccelerator

Clinical Accelerator announces collaboration with Reprieve Cardiovascular for developing a Cardiovascular system to treat Acute Decompensated Heart Failure

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Reprieve Cardiovascular, LLC for conducting a study aimed at optimally decongesting patients with Acute Decompensated Heart Failure (ADHF). The study will … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator collaborates with Thrombolytic Science International to study a tPA/mutant pro-urokinase dual regimen for thrombolysis in acute myocardial infarction

Clinical Accelerator, a full-service contract research organization, has entered into a collaboration with Thrombolytic Science International (TSI) to conduct a phase II randomised, multi-centre, open-label, parallel group mechanistic study using TSI’s dual treatment regimen in patients with ST elevation myocardial … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

Clinical Accelerator announces collaboration with Nasaleze International Ltd for a clinical study of Nasafort- a fast acting nasal spray for allergic rhinitis

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Nasaleze International Limited, for conducting a pivotal study for Nasafort: a nasally applied cellulose powder in seasonal allergic rhinitis (SAR) in … Continue reading

Posted in Uncategorized | Leave a comment

VisCardia Announces Completion of Enrollment and Three Month Follow-Up Visits for Its VisONE® Heart Failure Pilot Study

Below, we are re-publishing with permission the press-release issued by VisCardia Inc. on April 22, 2019 PORTLAND, Ore.–(BUSINESS WIRE)–VisCardia Inc., a privately held medical device developer, announced today it has completed enrollment and three month follow-up visits of the company’s … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

Clinical Accelerator announces collaboration with Archivel Farma in a phase IIa Clinical Trial for RUTI®: a therapeutic vaccination against Multi-Drug Resistant Tuberculosis

Clinical Accelerator, a full-service contract research organization, is pleased to announce that it has entered into a collaboration with Archivel Farma, for conducting a phase IIa clinical trial for their therapeutic vaccine RUTI® against multi-drug Resistant tuberculosis. The double-blind, randomized … Continue reading

Posted in Biotech, Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator | Leave a comment

The World’s First VisONE® Implantation: a promising start

Below, we are re-publishing with permission the press-release issued by the Heart Institute on the 28th of September 2018 “Thanks to the efforts of the study team from the Heart Institute, we have conducted the first worldwide implantation of the VisONE … Continue reading

Posted in Central and Eastern Europe, ClinAccel.Net, Clinical Accelerator, Medical Devices | Leave a comment

Temple Therapeutics BV Announces Publication of Key Mechanism Data for Evitar™

Below, we are re-publishing with permission the press-release issued by Temple Therapeutics BV on the 10th of September 2018 Supports Evitar’s™ Novel Approach for Preventing Acute Tissue Fibrosis (Surgical Adhesions) Geleen, The Netherlands Temple Therapeutics BV (the “Company” or “Temple”)- September … Continue reading

Posted in Biotech, Clinical Accelerator | Leave a comment